1. Home
  2. EARN vs RPID Comparison

EARN vs RPID Comparison

Compare EARN & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.82

Market Cap

200.3M

Sector

Real Estate

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$4.35

Market Cap

204.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
RPID
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.3M
204.3M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
EARN
RPID
Price
$4.82
$4.35
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.88
$8.00
AVG Volume (30 Days)
539.7K
160.1K
Earning Date
01-01-0001
04-02-2026
Dividend Yield
19.32%
N/A
EPS Growth
N/A
11.48
EPS
N/A
N/A
Revenue
N/A
$28,051,000.00
Revenue This Year
$8.43
$19.91
Revenue Next Year
$24.47
$21.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.57
52 Week Low
$4.33
$1.86
52 Week High
$6.46
$4.94

Technical Indicators

Market Signals
Indicator
EARN
RPID
Relative Strength Index (RSI) 31.46 56.07
Support Level N/A $3.03
Resistance Level $5.36 $4.46
Average True Range (ATR) 0.13 0.30
MACD -0.02 0.02
Stochastic Oscillator 11.21 77.05

Price Performance

Historical Comparison
EARN
RPID

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: